Your Compass for Pharma Success

FAILURE MODE AND EFFECTS ANALYSIS (FMEA) FOR INTRODUCTION OF NEW PRODUCT URSODEOXYCHOLIC ACID 300 mg TABLET IN EXISTING PHARMACEUTICAL FACILITY

Name: FAILURE MODE AND EFFECTS ANALYSIS (FMEA) FOR INTRODUCTION OF NEW PRODUCT URSODEOXYCHOLIC ACID 300 mg TABLET IN EXISTING PHARMACEUTICAL FACILITY
SKU: 12072
Price: 60.00 INR
Availability: InStock

FAILURE MODE AND EFFECTS ANALYSIS FOR INTRODUCTION OF NEW PRODUCT URSODEOXYCHOLIC ACID 300 mg TABLET IN EXISTING PHARMACEUTICAL FACILITY

Sale!

Original price was: ₹600.00.Current price is: ₹60.00.

Category: RISK ASSESSMENT Tags: AUDIT COMPLIANCE, AUDIT COMPLIANCE REPORT, FAILURE MODE EFFECT ANALYSIS, FEMA, FMEA, Incident, INVESTIGATION, INVESTIGATION REPORT, QUALITY RISK ASSESSMENT

Description

Description

THIS DOCUMENT IS APPLICABLE FOR

FAILURE MODE AND EFFECTS ANALYSIS (FMEA) FOR INTRODUCTION OF NEW PRODUCT

URSODEOXYCHOLIC ACID 300 mg TABLET IN EXISTING PHARMACEUTICAL FACILITY

FAILURE MODE AND EFFECTS ANALYSIS (FMEA) FOR INTRODUCTION OF NEW PRODUCT URSODEOXYCHOLIC ACID 300 mg TABLET IN EXISTING PHARMACEUTICAL FACILITY

Description

Related products

INVESTIGATION REPORT FOR OBSERVATION OF FLY IN MANUFACTURING CORRIDOR

INVESTIGATION REPORT FOR THE OBSERVATION OF LESS CARTON IN PACKED SHIPPER

INVESTIGATION REPORT FOR TDS OBSERVED OUT OF LIMIT IN PURIFIED WATER DURING ROUTINE QC TEST

INVESTIGATION REPORT FOR REFRIGERATOR DAILY TEMPERATURE MONITORING RECORD WAS NOT AVAILABLE

Leave a Reply Cancel reply